In a positive development for ASP Isotopes (ASPI, Financial), Canaccord Genuity analyst George Gianarikas has maintained a "Buy" rating for the company. This reaffirmation reflects continued confidence in the company's future prospects.
Furthermore, Gianarikas has raised the price target for ASPI from $8.50 to $11.00, marking a significant increase of 29.41%. The revised price target suggests strong potential for upside from the current market levels.
The rating and price target adjustment were made effective on May 21, 2025. The market will be closely watching how ASP Isotopes (ASPI, Financial) performs in the coming months following this notable endorsement.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for ASP Isotopes Inc (ASPI, Financial) is $7.75 with a high estimate of $11.00 and a low estimate of $4.50. The average target implies an downside of 2.58% from the current price of $7.96. More detailed estimate data can be found on the ASP Isotopes Inc (ASPI) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, ASP Isotopes Inc's (ASPI, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
